The first-in-human study showed no adverse events and a 100% rate of cecal intubation, where the endoscope is guided to the ...

Interruptions in the supply of neurosurgical patties, sponges and strips are expected to continue through 2026.

Mobia Medical has set the terms for its initial public offering, positioning the neurostimulation device company to raise ...

Insulet raised its revenue expectations for 2026 as the company brings more users onto its insulin patch pumps. The diabetes ...

The device joins a portfolio of vascular technologies that generated 9.5% sales growth on a comparable basis in the first ...

Mistras, who joins the heart valve company following two years as CFO at pharmaceutical firm Viatris, also brings investment ...

Roche has agreed to acquire PathAI, a Boston-based digital pathology firm, for up to $1.05 billion. Roche plans to pay $750 million upfront and up to $300 million in additional milestone payments, ...

Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.

The findings for patients 30 days after surgery were included in a package of data supporting J&J’s submission to the FDA for ...

Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where ...

The medtech company does not expect any material impact on its business or financial results, according to a filing with the ...

CEO Kevin Lobo said the attack had a “big impact” on first-quarter results. However, the company maintained its full-year ...